Nurse-led drug monitoring in the rheumatology clinic
Intended for healthcare professionals
Clinical Previous     Next

Nurse-led drug monitoring in the rheumatology clinic

Sarah Ryan Clinical Nurse Specialist in Rheumatology, At the Haywood Hospital, Burslem, Stoke-on-Trent

For rheumatology nurses, role extension means taking responsibility for monitoring the drugs used in the treatment of inflammatory arthritis. This article describes how nurse- led monitoring works in one clinic, and how it may offer a more holistic type of care

Nurses are increasingly incorporating into their skills areas of care traditionally undertaken by medical colleagues. In rheumatology, nurses have taken responsibility for monitoring disease-modifying antirheumatic drugs (DMARDs) and cytotoxic therapy. Phelan et al (1992) found that 86 per cent of rheumatology nurse specialists considered drug monitoring to be part of their role

Nursing Standard. 11, 24, 45-47. doi: 10.7748/ns.11.24.45.s52

Want to read more?

RCNi-Plus
Already have access? Log in

or

3-month trial offer for £5.25/month

Subscribe today and save 50% on your first three months
RCNi Plus users have full access to the following benefits:
  • Unlimited access to all 10 RCNi Journals
  • RCNi Learning featuring over 175 modules to easily earn CPD time
  • NMC-compliant RCNi Revalidation Portfolio to stay on track with your progress
  • Personalised newsletters tailored to your interests
  • A customisable dashboard with over 200 topics
Subscribe

Alternatively, you can purchase access to this article for the next seven days. Buy now


Are you a student? Our student subscription has content especially for you.
Find out more